| Syndax to Host ASH Investor Event in Person and via Webcast on December 14, 2026 |
Globe Newswire |
11/04 |
09:01 |
| Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026 |
Globe Newswire |
11/04 |
09:01 |
| Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and from Phase 1/2 2L Cohort in Patients with Relapsed/Refractory Large B-Cell Lymphoma |
Globe Newswire |
11/04 |
09:01 |
| Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Meeting |
Globe Newswire |
11/04 |
09:01 |
| Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting |
Globe Newswire |
11/04 |
09:01 |
| CRISPR Therapeutics to Present Clinical Data from Zugo-cel in Large B-Cell Lymphoma at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition |
Globe Newswire |
11/04 |
09:01 |
| Legend Biotech to Showcase CARVYKTI® Leadership and Next-Generation Cell Therapy Innovation at ASH 2026 |
Globe Newswire |
11/04 |
09:00 |
| Descope Unveils Envoy, an Identity-Aware Way For Personal AI Agents to Act on People’s Behalf |
Globe Newswire |
11/04 |
09:00 |
| Beam Therapeutics to Present Updated Clinical Data from BEACON Phase 1/2 Trial of Risto-cel in Sickle Cell Disease in an Oral Presentation at American Society of Hematology (ASH) Annual Meeting |
Globe Newswire |
11/04 |
09:00 |
| AI Automation Market Growth 2027: Microsoft, AWS, Accenture, ServiceNow and Salesforce Race to Scale Agentic Automation |
Globe Newswire |
11/04 |
09:00 |
| Umoja Biopharma Announces Oral Presentation of First UB-VV400 In Vivo CAR T Cell Therapy Clinical Data and Four Total Presentations at the 68th ASH Annual Meeting |
Globe Newswire |
11/04 |
09:00 |
| Momentive Software Research Finds Members Want Associations to Lead on Innovation, but Professionals Rank it Near the Bottom |
Globe Newswire |
11/04 |
09:00 |
| Automotive CX Research Finds AI Demand Rising as Service Levels Stagnate |
Globe Newswire |
11/04 |
09:00 |
| Skechers USA, Inc. (NYSE: SKX) SHAREHOLDER ALERT: Investors with Losses may Seek to Lead the Class Action in Skechers USA, Inc. Securities Lawsuit - Contact Portnoy Law Firm |
Globe Newswire |
11/04 |
09:00 |
| Did You Lose Money on NVE Corporation Stock? The Law Offices of Howard G. Smith Continues Securities Fraud Investigation After 33.68% Share Price Decline |
Globe Newswire |
11/04 |
09:00 |
| Vivakor Highlights Direct Midstream’s New Mexico Operating Agreement as Proposed Acquisition Advances |
Globe Newswire |
11/04 |
09:00 |
| Castor Maritime Announces that MPC Oceanic Group Has Entered into Agreement to Acquire a 41% Stake in Marlow Navigation |
Globe Newswire |
11/04 |
09:00 |
| Yiren Digital (NYSE: YRD) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Yiren Digital Securities Lawsuit - Contact Portnoy Law Firm |
Globe Newswire |
11/04 |
09:00 |
| Caribou Biosciences Announces Presentations at the 2026 American Society of Hematology (ASH) Annual Meeting |
Globe Newswire |
11/04 |
09:00 |
| Cellectar Biosciences to Present Three Posters Highlighting Durable Clinical Activity of Iopofosine I 131 in Waldenström Macroglobulinemia at the American Society of Hematology Annual Meeting and Exposition |
Globe Newswire |
11/04 |
09:00 |
| Kamau Therapeutics Announces First Multi-Patient Clinical Data Showing Precise Correction of the Sickle Cell Mutation and Restoration of Adult Hemoglobin |
Globe Newswire |
11/04 |
09:00 |
| Syndax Highlights Acceptance of 19 Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Abstracts, Including 7 for Oral Presentation, at ASH 2026 |
Globe Newswire |
11/04 |
09:00 |
| Peer-Reviewed Scientific Journal Publishes U.S. Clinical Study Reporting Interim Results of 87.7% Accuracy for IR-MED’s PressureSafe™ Technology in Pressure-Injury Assessment |
Globe Newswire |
11/04 |
09:00 |
| Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026 |
Globe Newswire |
11/04 |
09:00 |
| O-I Glass, Inc. (NYSE: OI) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in O-I Glass, Inc. Securities Lawsuit - Contact Portnoy Law Firm |
Globe Newswire |
11/04 |
09:00 |
